ArnettCDShiueC-YWolfAPFowlerJSLoganJWatanabeM, (1985) Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. J Neurochem44:835–844
2.
MintunMARaichleMEKilbournMRWootenGFWelchMJ, (1984) A quantitative model for in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol15:217–227
3.
PerlmutterJSLarsonKBRaichleMEMarkhamJMintunMAKilbournMRWelchMJ, (1986) Strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab6:154–169
4.
PerlmutterJSRaichleME, (1987) (Response To) Concerning strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab7:253–255
5.
WongDFGjeddeAWagnerHN, (1986a) Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands. J Cereb Blood Flow Metab6:137–146
6.
WongDFGjeddeAWagnerHNDannalsRFDouglassKHLinksJMKuharMJ, (1986b) Quantification of neuro-receptors in the living human brain. II. Inhibition studies of receptor density and affinity. J Cereb Blood Flow Metab6:147–153
ZeebergBRBiceANWagnerHN, (1987) Concerning strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab7:252–253
